Heart transplantation in a patient with chloroquine-induced cardiomyopathy

J Heart Lung Transplant. 2004 Feb;23(2):252-5. doi: 10.1016/S1053-2498(03)00108-6.


We present the first report of a patient who underwent heart transplantation (HT) after endomyocardial biopsy (EMB) and revealed chloroquine-induced cardiomyopathy (CIC). This patient, who was treated with chloroquine for 6 years, developed a restrictive cardiomyopathy that progressed to congestive heart failure (CHF) resistant to medical management.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy*
  • Cardiomyopathy, Restrictive / chemically induced*
  • Cardiomyopathy, Restrictive / surgery*
  • Chloroquine / adverse effects*
  • Chloroquine / therapeutic use
  • Female
  • Heart Failure / chemically induced
  • Heart Failure / surgery
  • Heart Transplantation*
  • Humans
  • Middle Aged
  • Time Factors


  • Antirheumatic Agents
  • Chloroquine